Highlighting the Mechanism of GLP-1 Analogues & Demonstrating Their Promise to Reduce Neurodegenerative Diseases
Time: 4:30 pm
day: Conference Day Two PM
Details:
- Overview of the different mechanism by which GLP-1 analogues work
- Reduction of neuroinflammation, Tau, Influence on insulin resistance, astrocyte etc.
- Clinical studies evaluating GLP-1 analogues in Alzheimer’s disease and Parkinson’s disease
- Potential mechanism on other neurodegenerative processes
